Total investments received (USD): 57.01m
Round value (USD): 8.61m
Round investors:
415 Capital
Company: CorFlow Therapeutics


Belgium
Netherlands
Austria
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom